Gulf Pharmaceutical Industries (Julphar) on Friday announced a net revenue of AED273.4 million from continuing operations in Q1 2026, reflecting a year-on-year decrease of 3.0 percent, while delivering improved profitability.
Julphar (Gulf Pharmaceutical Industries) has signed a long-term lease agreement with Modon 3rd Industrial City in Jeddah to establish an integrated pharmaceutical manufacturing facility.
Julphar (Gulf Pharmaceutical Industries) said it has entered into a long-term lease agreement with Modon Industrial City for setting up its integrated pharmaceutical manufacturing plant in the Saudi Arabia over a 45,000 sq m area at Jeddah.
